GLENN SCHROYER: Open Payments
NPI 1336168780 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,542 in 124 payments from 21 companies in 2025. Trend: 2023 $2,853 · 2024 $2,631 · 2025 $2,542
Food & beverage: $2,542
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $448 |
| AstraZeneca Pharmaceuticals LP | 18 | $372 |
| Novo Nordisk Inc | 13 | $259 |
| GlaxoSmithKline, LLC. | 12 | $257 |
| PFIZER INC. | 15 | $250 |
| Exact Sciences Corporation | 7 | $139 |
| Otsuka America Pharmaceutical, Inc. | 5 | $118 |
| Lilly USA, LLC | 4 | $98 |
| Lundbeck LLC | 4 | $91 |
| Axsome Therapeutics, Inc. | 4 | $83 |
Products named: QULIPTA, REXULTI, AIRSUPRA, SHINGRIX, NURTEC ODT, BREZTRI, Ozempic, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
